Research progress and nursing enlightenment of patient-reported outcome measures for cancer immuno-therapy
- 作者单位
- eDepartment of Respiratory Medicine, Cancer Hospital of Shandong First Medical University, Ward 2, Jinan, 250021, China cDepartment of Radiology, Cancer Hospital of Shandong First Medical University, Jinan, 250021, China aSchool of Nursing, Shandong First Medical University, Jinan, 250117, China gDepartment of Health Management, Taishan Vocational College of Nursing, Taian, 271000, China dDepartment of [Prevention Management, Cancer Hospital of Shandong First Medical University, Jinan, 250021, China bCancer Hospital of Shandong First Medical University, Ovarian Oncology Ward, Jinan, 250021, China fthe First Department of Psychiatry, Weifang Mental Health Center, Female Ward, Weifang, 261000, China
- 刊名
- Chinese Journal of Nursing
- 年份
- 2026
- 卷号
- Vol.61 No.3
- 页码
- 419-427
- ISSN
- 0254-1769
- 摘要
- With the widespread application of immunotherapy in cancer patients,immune-related adverse events have become a key focus of clinical attention. Accurately assessing these adverse reactions and their impact on patients' health-related quality of life is an indispensable part of cancer immunotherapy. This article reviews the research progress of patient-reported outcomes,and summarizes the existing patient reported outcomes scale for cancer immunotherapy from two aspects of universality and speci...更多
- 文献类型
- 期刊
-
被引次数
-
收录
Scopus